Herbert M. Stein
Amministratore Delegato presso Apogee Technology, Inc.
Profilo
Herbert M.
Stein is currently the President, CEO, CFO, Secretary & Director at Apogee Technology, Inc. He previously served as the Chairman & Chief Executive Officer at Organogenesis, Inc. from 1987 to 1999.
Posizioni attive di Herbert M. Stein
Società | Posizione | Inizio |
---|---|---|
Apogee Technology, Inc.
Apogee Technology, Inc. Medical SpecialtiesHealth Technology Apogee Technology, Inc. is a biotechnology company which develops proprietary systems for the delivery of pharmaceutical agents into the skin for the treatment and prevention of local and systemic conditions. The company was founded in 1987 and is headquartered in Norwood, MA. | Amministratore Delegato | - |
Precedenti posizioni note di Herbert M. Stein
Società | Posizione | Fine |
---|---|---|
Organogenesis, Inc.
Organogenesis, Inc. Medical SpecialtiesHealth Technology Organogenesis, Inc. designs and manufactures regenerative medical products. It offers Apligraf, a living cell-based product indicated for the treatment of venous leg ulcers and diabetic foot ulcers and Dermagraft, a product for the treatment of diabetic foot ulcers. The firm also provides bioactive wound healing, biosurgery, and aesthetic medicine containing living cells and natural connective tissues. The company was founded in 1985 and is headquartered in Canton, MA. | Amministratore Delegato | 01/01/1999 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Apogee Technology, Inc.
Apogee Technology, Inc. Medical SpecialtiesHealth Technology Apogee Technology, Inc. is a biotechnology company which develops proprietary systems for the delivery of pharmaceutical agents into the skin for the treatment and prevention of local and systemic conditions. The company was founded in 1987 and is headquartered in Norwood, MA. | Health Technology |
Organogenesis, Inc.
Organogenesis, Inc. Medical SpecialtiesHealth Technology Organogenesis, Inc. designs and manufactures regenerative medical products. It offers Apligraf, a living cell-based product indicated for the treatment of venous leg ulcers and diabetic foot ulcers and Dermagraft, a product for the treatment of diabetic foot ulcers. The firm also provides bioactive wound healing, biosurgery, and aesthetic medicine containing living cells and natural connective tissues. The company was founded in 1985 and is headquartered in Canton, MA. | Health Technology |
- Borsa valori
- Insiders
- Herbert M. Stein